Full Service CRO

Since 1992, we have completed over 400 studies successfully and continue to serve clients globally. CMX focuses on clinical excellence from Proof of Concept Studies, Early Phase Trials through to PRE and POST-Marketing studies, Pivotal Trials and Real World Registries.

Contact us to manage your clinical trial.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Urology • Oncology • Immunology • Cardiology • Dermatology • Endocrinology • Respirology • Medical Devices

    Our Services

    CMX understands the importance and complexity of Phase I-IV clinical trials. We offer the following services.

    Study Design icon

    Project Management

    With the completion of over 400 clinical trials in the last 26 years, CMX has the expertise and experience to successfully manage your clinical study.

    Site Monitoring and Training Icon

    Site Monitoring And Training

    CMX has highly qualified CRAs that ensure compliance with your drug or device study. Phase I – IV as well as BA/BE studies are monitored according to ICH GCP. They are experienced and attend ongoing educational seminars to monitor SQVs, SIVs, IMVs and COVs effectively and efficiently.

    Regulatory Affairs Icon

    Regulatory Affairs

    CMX has an established relationship with Health Canada and other global regulatory bodies including the FDA. Clinical Trial Applications (CTAs) and notifications are executed effortlessly. CMX works with both central and local ethics boards to obtain approval in a timely manner.


    Vendor Procurement Icon

    Vendor Procurement

    CMX has established and ongoing relationships with their vendors. A rigorous audit process is conducted prior to working with any vendor as well as periodic evaluations.

    Medical Writing And Communication Icon

    Medical Writing And Communication

    Let CMXs experts provide your company with medical writing and communication services.

    Safety And Medical Monitoring Icon

    Safety And Medical Monitoring

    CMX has a team of highly qualified specialists to conduct safety and medical monitoring. They are experienced principal investigators, department heads and highly skilled urologists.

    Statistical Analysis Icon

    Statistical Analysis

    All your needs are met for an interim analysis or final CSR while evaluating the primary objective and endpoints of your protocol. Our medical statisticians have over 18 years of experience in clinical trials.

    Protocol Writing Icon

    Protocol Writing, Study Design & CSR

    Dr. Richard Casey has written multiple protocols and has contributed to the design of sponsors' protocols. With 40 years of experience, his input in study design is invaluable.

    Data Mangement Icon

    Data Management (eDc)

    CMX partners with top data management vendors. CMX caters to the needs of your clinical trial.


    With exceptional project management, our studies are conducted on time, within budget and in accordance with ICH GCP guidelines.

    CMX focuses on clinical excellence from Proof of Concept Trials through the delivery of pre-marketing and pivotal trials to post-registration support.

    Some of our Current Studies

    • A Single, Blind, Two-Stage Dose-Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection into the Prostate in Patients with Localized Prostate Cancer, Assigned to Active Surveillance who are at High Risk for Disease Progression (followed by an Open Label Extension with a Repeat Injection (Optional))

    • Androgen Deprivation with Goserelin Acetate (Zoladex®): An Assessment of The Standard of Care in Early and Late Stage Prostate Cancer in Canada. A Real World Observational Registry (ZOLAPT)

    • A Prospective, Single Arm Study in Prostate Cancer Patients Managed with Androgen Deprivation Therapy to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training (ELIFIT)

    • A Canadian Observational Study in Metastatic Cancer of the Prostate: A study of Zytiga Use in the Community Urology Setting. The COSMIC Prospective Prostate Cancer Study

    • A 150-Day, Prospective, Phase IV, Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement when Treating Male Hypogonadism with Testosterone Nasal Gel (Natesto™) My-T Study

    • Validation Study: A Prospective, Non-Randomized, Single Arm Trial To Assess The Efficacy Of The Comfort Plug™ In Preventing Urinary Incontinence In Male Subjects With Sphincteric Incompetence (COMFORT STUDY)

    • Parallel Group Single Blind Study to Compare the Pharmacokinetic Profiles and Pharmacodynamic Response of a drug XXXX in Ambulatory Patients with Advanced Carcinoma of the Prostate

    • Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients Managed with Lupon: (CRONOS II)

    And many more...


    Let CMX Research Inc. plan and implement your Clinical Development Programs. Please fill in the form below or call us at 1-877-290-0018.

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.